Follicular lymphoma (FL) is the most common indolent non‐Hodgkin lymphoma in the
Western hemisphere. The natural history of FL appears to have been favorably impacted by …

Disease overview Follicular lymphoma is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma (FL) is characterized by …

Follicular lymphoma (FL) is the most common indolent lymphoma in the United States with
an incidence of 3.4 patients per 100,000 and an estimated 13,960 new patients diagnosed …

Follicular lymphoma (FL) is the second most common lymphoma, and by virtue of its
chronicity, may be the most prevalent and most treated lymphoma in the United States …

7527 Background: Initial treatment strategies in FL include observation (obs), rituximab (R),
chemotherapy±R, and XRT. A recent study suggests initial therapy may impact FL survival …

We assessed stage-specific trends in primary therapy and relative survival among adult
follicular lymphoma (FL) patients diagnosed in the Netherlands between 1989–2016 (N …

Although the introduction of immunotherapy has improved outcomes for follicular lymphoma
(FL) patients, histological transformation (HT) and early relapse still confer a poor prognosis …

Aim The prognosis and treatment options for follicular lymphoma (FL) remain heterogenous.
This study aimed to analyze the prognostic impact of rituximab maintenance and evaluate …

Clinical features and outcomes of FL patients in Chinese population are limited, thus
promoting us to perform this analysis on a large cohort of 1845 patients with FL enrolled …

For the majority of patients with newly diagnosed follicular lymphoma (FL), current
treatments, while not curative, allow for long remission durations. However, several …